Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-23-005593

CVP,Strategy/Corp Development sold 5,635 shares at $88.63 ($499,402)

  • CVP,Strategy/Corp Development gave up 4,367 shares (to pay taxes)
  • CVP,Strategy/Corp Development acquired 4,767 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

BOBO DONALD E JR · CVP,Strategy/Corp Development

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2023-05-05 Sale : show line 1 in the form −5,635 $88.63 $499,402 56,224.69 D
2023-05-07 Exercise or conversion : show line 2 in the form +4,767 60,991.69 D
2023-05-07 Shares withheld for taxes : show line 3 in the form −2,968 $88.74 $263,380 58,023.69 D
2023-05-08 Shares withheld for taxes : show line 4 in the form −1,399 $88.74 $124,147 56,624.69 D
Open-market sales · 5,635 sh · avg $88.63 · $499,402

Table II: Derivative

1 line
Date Transaction Shares Expires Underlying Owned after D/I
2023-05-07 Exercise or conversion : show line 5 in the form Performance Rights −4,767 2027-05-06 4,767 1,308 D
Loading xslF345X04/doc4.xml…